Product Images Oxaliplatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Oxaliplatin NDC 71288-101 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

oxa0h 0002 01

oxa0h 0002 01

oxa0h 0002 02

oxa0h 0002 02

oxa0h 0002 03

oxa0h 0002 03

oxa0h 0002 04

oxa0h 0002 04

The given text contains information regarding the median survival for two types of injections i.e. Oxalpatin injection, USP + SFULY and Oxaliplatin Injection plus natecan. The median survival for the former was 19.4 months while for the latter, it was 178 months. A log-rank test was carried out to compare the two injections. Therefore, the text provides data on the comparative efficacy of two injections used in a medical context.*

oxa0h 0002 05

oxa0h 0002 05

NDC 71288-101-10 is a medication called Oxaliplatin and is available as an injection. It is a cytotoxic agent and should only be used intravenously. The medication comes in a 10 mL single-dose vial and should only be used with chloride-containing solutions. The manufacturer is Meitheal Pharmaceuticals, and it was made in India in 2018. Batch details can be printed online.*

oxa0h 0002 06

oxa0h 0002 06

Each vial of this medication contains Oxaliplatin, USP 50mg and sterile Water for Injection, USP (10/mL). The package insert should be consulted for dosage and further instructions. This medication is a cytotoxic agent for intravenous use only and is not to be mixed with or added to solutions containing sodium chloride. It should be stored at room temperature between 20°C and 25°C (68°F and 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Unused portions should be discarded, and the package insert should be consulted for storage instructions for further diluted solutions. NDC numbers and manufacturer information are also provided.*

oxa0h 0002 07

oxa0h 0002 07

NDC 71288-101-20 is a single-dose injection of Oxaliplatin, a cytotoxic agent for intravenous use only, manufactured by Meitheal Pharmaceuticals. It contains 100mg of Oxaliplatin per 20mL and should not be mixed or added to sodium chloride or chloride-containing solutions. Batch details are available online.*

oxa0h 0002 08

oxa0h 0002 08

This seems to be a description of a medication called cARo0sase02 contained in a vial. Each vial contains Oralpltin, USP 100mg and water for injection. The dosage and administration instructions are available in the package insert. It must be stored at 20° to 25°C and should not be frozen. The medication is a cytotoxic agent for intravenous use only. It should not be mixed with sodium chloride-containing solutions and has a sterile aqueous solution that is preservative-free. Further details on its storage are available in the package insert.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.